Your browser doesn't support javascript.
loading
Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).
Jensen, Mathias Ebbesen; Stenbæk, Dea Siggaard; Juul, Tobias Søgaard; Fisher, Patrick MacDonald; Ekstrøm, Claus Thorn; Knudsen, Gitte Moos; Fink-Jensen, Anders.
Afiliação
  • Jensen ME; Psychiatry Centre Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark mathias.ebbesen.jensen.01@regionh.dk.
  • Stenbæk DS; Department of Neurology and Neurobiology Research Unit, Copenhagen University Hospital, Copenhagen, Denmark.
  • Juul TS; Department of Psychology, University of Copenhagen, Copenhagen, Denmark.
  • Fisher PM; Psychiatry Centre Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.
  • Ekstrøm CT; Department of Neurology and Neurobiology Research Unit, Copenhagen University Hospital, Copenhagen, Denmark.
  • Knudsen GM; Department of Public Health, Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark.
  • Fink-Jensen A; Department of Neurology and Neurobiology Research Unit, Copenhagen University Hospital, Copenhagen, Denmark.
BMJ Open ; 12(10): e066019, 2022 10 14.
Article em En | MEDLINE | ID: mdl-36241352

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alcoolismo / Alucinógenos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alcoolismo / Alucinógenos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Dinamarca